Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Inhibition of p16 tumor suppressor gene expression via promoter hypermethylation in canine lymphoid tumor cells.

Fujiwara-Igarashi A, Goto-Koshino Y, Mochizuki H, Sato M, Fujino Y, Ohno K, Tsujimoto H.

Res Vet Sci. 2014 Aug;97(1):60-3. doi: 10.1016/j.rvsc.2014.04.008. Epub 2014 Apr 24.

PMID:
24815345
2.

Hypermethylation of the death-associated protein kinase CpG island in canine B-cell lymphoid tumors.

Sato M, Mochizuki H, Goto-Koshino Y, Fujiwara-Igarashi A, Takahashi M, Fujino Y, Ohno K, Tsujimoto H.

Vet Immunol Immunopathol. 2014 Oct 15;161(3-4):222-31. doi: 10.1016/j.vetimm.2014.08.011. Epub 2014 Aug 23.

PMID:
25193469
4.

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y.

Cancer Res. 2003 Jul 15;63(14):4174-80.

5.

High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.

Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.

Mol Carcinog. 2002 Oct;35(2):85-92.

PMID:
12325038
6.

Prognostic significance of the expression levels of the p16, p15, and p14 genes in dogs with high-grade lymphoma.

Fujiwara-Igarashi A, Goto-Koshino Y, Sato M, Maeda S, Igarashi H, Takahashi M, Fujino Y, Ohno K, Tsujimoto H.

Vet J. 2014 Feb;199(2):236-44. doi: 10.1016/j.tvjl.2013.11.004. Epub 2013 Nov 13.

PMID:
24365070
7.

The p16-specific reactivation and inhibition of cell migration through demethylation of CpG islands by engineered transcription factors.

Zhang B, Xiang S, Zhong Q, Yin Y, Gu L, Deng D.

Hum Gene Ther. 2012 Oct;23(10):1071-81. doi: 10.1089/hum.2012.070. Epub 2012 Aug 27.

8.

Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.

Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA.

Cancer Res. 1995 Oct 15;55(20):4531-5.

9.

Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.

Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R.

Cancer Res. 2002 Jul 1;62(13):3698-701.

10.

Frequent aberrant methylation of p16INK4a in primary rat lung tumors.

Swafford DS, Middleton SK, Palmisano WA, Nikula KJ, Tesfaigzi J, Baylin SB, Herman JG, Belinsky SA.

Mol Cell Biol. 1997 Mar;17(3):1366-74.

11.

Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.

Guo SX, Taki T, Ohnishi H, Piao HY, Tabuchi K, Bessho F, Hanada R, Yanagisawa M, Hayashi Y.

Leuk Res. 2000 Jan;24(1):39-46.

PMID:
10634644
12.

Expression of the p16INK4a gene and methylation pattern of CpG sites in the promoter region in rat tumor cell lines.

Honoki K, Tsujiuchi T, Mori T, Yoshitani K, Tsutsumi M, Takakura Y, Mii Y.

Mol Carcinog. 2004 Jan;39(1):10-4.

PMID:
14694443
13.

Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.

Nagasawa T, Zhang Q, Raghunath PN, Wong HY, El-Salem M, Szallasi A, Marzec M, Gimotty P, Rook AH, Vonderheid EC, Odum N, Wasik MA.

Leuk Res. 2006 Mar;30(3):303-12. Epub 2005 Sep 26.

PMID:
16185764
14.

Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.

Chim CS, Wong KY, Loong F, Lam WW, Srivastava G.

Hum Pathol. 2007 Dec;38(12):1849-57. Epub 2007 Sep 27.

PMID:
17900658
15.

Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.

Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, Otterson GA.

Oncogene. 2001 Nov 22;20(53):7787-96.

16.

Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients.

Tomiyasu H, Goto-Koshino Y, Fujino Y, Ohno K, Tsujimoto H.

Vet J. 2014 Jan;199(1):103-9. doi: 10.1016/j.tvjl.2013.10.022. Epub 2013 Oct 30.

PMID:
24332606
17.

Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma.

Bryan JN, Jabbes M, Berent LM, Arthur GL, Taylor KH, Rissetto KC, Henry CJ, Rahmatpanah F, Rankin WV, Villamil JA, Lewis MR, Caldwell CW.

BMC Genet. 2009 Nov 13;10:73. doi: 10.1186/1471-2156-10-73.

18.
19.
20.

Simultaneous inactivation of the p16, p15 and p14 genes encoding cyclin-dependent kinase inhibitors in canine T-lymphoid tumor cells.

Fujiwara-Igarashi A, Goto-Koshino Y, Mochizuki H, Maeda S, Fujino Y, Ohno K, Tsujimoto H.

J Vet Med Sci. 2013;75(6):733-42. Epub 2013 Jan 24.

Supplemental Content

Support Center